We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAKT icon
901
Daktronics
DAKT
$962M
$885K 0.01%
58,500
– –
DTSQ
902
DT Cloud Star Acquisition Corp
DTSQ
$41.5M
$882K 0.01%
168,000
+84,000
+100% +$867K
TOL icon
903
Toll Brothers
TOL
$14.2B
$879K 0.01%
7,700
– –
LCCCU
904
Lakeshore Acquisition III Corp Unit
LCCCU
$878K 0.01%
+86,100
New +$869K
NEO icon
905
NeoGenomics
NEO
$1.76B
$870K 0.01%
119,000
+20,000
+20% +$161K
BAM icon
906
Brookfield Asset Management
BAM
$75.7B
$869K 0.01%
15,724
– –
AMCX icon
907
AMC Global Media
AMCX
$452M
$843K 0.01%
134,500
-1,500
-1% -$9.47K
VMD icon
908
Viemed Healthcare
VMD
$459M
$840K 0.01%
121,510
+5,000
+4% +$33.9K
EGBN icon
909
Eagle Bancorp
EGBN
$872M
$838K 0.01%
43,000
-1,200
-3% -$22.3K
LVS icon
910
Las Vegas Sands
LVS
$31.4B
$835K 0.01%
19,200
– –
ELMD icon
911
Electromed
ELMD
$325M
$814K 0.01%
37,000
– –
BANC icon
912
Banc of California
BANC
$3.26B
$800K 0.01%
+56,968
New +$776K
HAE icon
913
Haemonetics
HAE
$3.65B
$797K 0.01%
+10,682
New +$707K
MAT icon
914
Mattel
MAT
$4.23B
$789K 0.01%
40,000
– –
ARTNA icon
915
Artesian Resources
ARTNA
$355M
$789K 0.01%
23,500
– –
GTN.A icon
916
Gray Media Inc
GTN.A
$709M
$779K 0.01%
71,700
– –
MSI icon
917
Motorola Solutions
MSI
$70.1B
$778K 0.01%
1,850
– –
SHAK icon
918
Shake Shack
SHAK
$2.46B
$773K 0.01%
5,500
-500
-8% -$54.5K
A icon
919
Agilent Technologies
A
$39.1B
$772K 0.01%
+6,546
New +$725K
AXGN icon
920
Axogen
AXGN
$2.16B
$772K 0.01%
+71,138
New +$932K
EURK
921
Eureka Acquisition Corp
EURK
$25.9M
$754K 0.01%
72,300
– –
TS icon
922
Tenaris
TS
$28.6B
$748K 0.01%
20,000
– –
MFIN icon
923
Medallion Financial
MFIN
$229M
$743K 0.01%
78,000
-2,000
-3% -$18.1K
ASPC
924
A SPAC III Acquisition Corp
ASPC
$24.8M
$736K 0.01%
+71,800
New +$729K
PRG icon
925
PROG Holdings
PRG
$1.76B
$734K 0.01%
25,000
-2,500
-9% -$69.4K
35 36
37
38 39

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.